Rapamycin-Related Problems Probed
Treatment with rapamycin may be associated with myoglobinuria and severe acute renal failure (ARF) following renal transplantation, according to a new study.
Print Issue: December 01, 2006
Network May Improve Transplant Care
TORONTO—A new online communication system under development promises to allow the tracking of every tissue or organ from donor to recipient in the United States. Such a system could reduce morbidity and mortality from donor-derived diseases.
Naftopidil Monotherapy Is Sufficient
Naftopidil is effective first-line monotherapy for patients with storage symptoms associated with benign prostatic hyperplasia (BPH), according to researchers in Japan.
Medication Protects Bone in PCa Patients
PHILADELPHIA—Prostate cancer patients treated with luteinizing hormone- releasing hormone (LHRH) have increased bone turnover and rapid bone loss within six months. A recent study suggests that this can be prevented with risedronate 35 mg once a week.
Wrong-Site Surgery More Common Than Thought
While coverage of wrong-side, wrong-site, wrong-procedure, and wrong-patient surgery occasionally appears in the lay press, it has been virtually nonexistent in the medical literature.
Botched Surgery Leads to $3.9 Million Verdict
A jury in Staten Island, N.Y., awarded $3.9 million to a man who experienced complications following vascular surgery.
Errors Factor in Most Malpractice Claims
Medical errors caused by missed and delayed diagnoses in the outpatient setting result in significant harm to patients, according to a recent review of medical malpractice claims.
Lower PSA Biopsy Cutoff Supported
African-American (AA) men with nonpalpable prostate cancer have greater cancer volumes and higher prostatectomy Gleason scores than white men with similar PSA levels at the time of biopsy, according to a study.
A Respected Urologist Misses Prostate Cancer
Dr. R is a successful urologist who had gathered a wide circle of referring physicians over his 15 years in urologic practice, and he prided himself on his diagnostic acumen. But a missed case of prostate cancer dragged him into a malpractice suit.
Higher PSA Hikes Rescue Failure Risk
PSA levels and PSA doubling time (PSADT) prior to radiotherapy predict outcomes following rescue radiation therapy for men with prostate cancer.
- Loading...
Loading...
Loading... 
Loading...